A research Consortium to define the function of MeCP2: A step towards the development of therapeutics for treating Rett Syndrome
Reference: Adrian Bird Abstract: n.a PROJECT DETAILS beginning: 2011. end: 2014. Country of research: United Kingdom Counry of funding source: United States Funding organization: Rett Syndrome Research Trust Financing: PRIVATE FUNDERS – 442 254 € hyperlink